Search Results - "Pamen, Bouba"
-
1
PA-352 Detectable low-level viremia among people living with HIV in Cameroon suggests a revised threshold for viral suppression: evidence in the era of dolutegravir-based ART
Published in BMJ global health (17-12-2023)“…BackgroundTransitioning to dolutegravir-based therapy in Cameroon has improved viral suppression (VS) rates, known as low-level viremia (LLV) <1000copies/ml…”
Get full text
Journal Article -
2
Evaluation of archived drug resistance mutations in HIV‐1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID‐19 pandemic
Published in HIV medicine (01-06-2023)“…Background With the success of antiretroviral therapy (ART), children born with HIV are more likely to reach adolescence. However, frequent non‐adherence to…”
Get full text
Journal Article -
3
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
Published in Viruses (01-08-2023)“…Increased HIV drug resistance (HIVDR) with antiretroviral therapy (ART) rollout may jeopardize therapeutic options, especially in this era of transition to…”
Get full text
Journal Article -
4
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
Published in Viruses (28-06-2023)“…The efficacy of first-line antiretroviral therapy (ART) may be hampered by the presence of HIV drug resistance (HIVDR). We described HIV-1 pre-treatment drug…”
Get full text
Journal Article -
5
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
Published in Viruses (21-12-2022)“…To ensure optimal prescribing practices in the dolutegravir-era in Cameroon, we compared first-line virological response (VR) under tenofovir + lamivudine +…”
Get full text
Journal Article -
6
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
Published in Microbiology spectrum (21-12-2022)“…To ensure the long-term efficacy of dolutegravir (DTG), we evaluated the genotypic profile in viral reservoirs among patients on third-line (3L) antiretroviral…”
Get full text
Journal Article -
7
Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
Published in Medicine (Baltimore) (19-05-2023)“…This study aimed to compare viral suppression (VS) between children, adolescents, and adults in the frame of transition to dolutegravir (DTG)-based…”
Get full text
Journal Article -
8
Mental health troubles among Cameroonian adolescents perinatally infected with Human Immunodeficiency Virus
Published in Revue d'épidémiologie et de santé publique (01-06-2023)“…Adolescents living with HIV are more likely to experience mental health challenges compared to their peers who do not have HIV. However, there is a lack of…”
Get more information
Journal Article